^

Health

A
A
A

Age-related changes in cellular immunity in children

 
, medical expert
Last reviewed: 23.04.2024
 
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

In the diagnosis of various disease states in the immunocompetent system of both the fetus and the newborn child and children of later life periods, methods of determining the degree of maturity and differentiation of individual populations or subpopulations of lymphocytes are of great importance. Determine the relative and absolute contents of lymphocytes with those or other immunological marker signs. There are normative data for judging the degree of norm or pathological deviations in the population composition of blood lymphocytes in children of different ages and adults.

The number of lymphocytes and their subpopulations in human umbilical cord blood

Indicators

Relative,%

Absolute, μL

Minimum

Maximum

Minimum

Maximum

Leukocytes

-

-

10 LLC

15,000

Lymphocytes

35

47

4200

6900

CD3 (T-cells)

49

62

2400

3700

CD4 (T-helpers)

28

42

1500

2400

CD8 (T-killers)

26th

33

1200

2000

CD4 / CD8

0.8

1.8

-

-

CD16 (NK cells)

8

17th

440

900

CD20 (B-lymphocytes)

14

23

700

1500

CD25 (receptor for IL-2)

5.5

10

302

550

HLA II

16

27th

880

1485

The number of lymphocytes and their subpopulations in peripheral blood of children under 1 year

Indicators

Relative,%

Absolute, μL

Minimum

Maximum

Minimum

Maximum

Leukocytes

-

-

6400

11 000

Lymphocytes

39

59

2700

5400

CD3 (T-cells)

58

67

1900

3600

CD4 (T-helpers)

38

50

1500

2800

CD8 (T-killers)

18

25

800

1200

CD4 / CD8

1.5

2.9

-

-

CD16 (NK cells)

8

17th

300

700

CD20 (B-lymphocytes)

19

31

500

1500

CD25 (receptor for IL-2)

7th

12

280

360

HLA II

25

38

1000

1520

The number of lymphocytes and their subpopulations in peripheral blood of children 1-6 years

Indicators

Relative,%

Absolute, μL

Minimum

Maximum

Minimum

Maximum

Leukocytes

-

-

4700

7300

Lymphocytes

36

43

2000

2700

CD3 (T-cells)

66

76

1400

2000

CD4 (T-helpers)

33

41

700

1100

CD8 (T-killers)

27th

35

600

900

CD4 / CD8

1.0

1.4

-

-

CD16 (NK cells)

9

16

200

300

CD20 (B-lymphocytes)

12

22

300

500

CD25 (receptor for IL-2)

10

16

230

368

HLAII

19.5

39

449

897

The number of lymphocytes and their subpopulations in human peripheral blood of 18-60 years

Indicators

Relative,%

Absolute, μL

Minimum

Maximum

Minimum

Maximum

Leukocytes

-

-

4000

8000

Lymphocytes

28

39

1600

2400

CD3 (T-cells)

50

76

800

1216

CD4 (T-helpers)

31

46

500

900

CD8 (T-killers)

26th

40

416

640

CD4 / CD8

1.0

1.5

-

-

CD16 (NK cells)

9

16

170

400

CD20 (B-lymphocytes)

Eleven

16

200

400

CD25 (receptor for IL-2)

13

24

208

576

HLA II

19

Thirty

340

720

CD95

5

7th

90

112

Characteristics of the characteristics of the immune response are largely determined by the ability of participating cells to produce substances of humoral communication and regulation - cytokines or interleukins. In scientific research, several dozens of such information and regulatory molecules have been identified and quantified. In clinical immunology, the most important is the determination of 10-15 biologically active substances of this group.

Naturally, in the diagnosis of paramount importance are research methods that carry the ability to quantify the production of certain active molecules. This is particularly convincingly achieved in stimulation or induced synthesis reactions under standard culture conditions of lymphocytes.

trusted-source[1], [2], [3], [4], [5], [6]

Translation Disclaimer: For the convenience of users of the iLive portal this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.